A SINGLE CENTER, OPEN LABEL, FIXED SEQUENCE STUDY TO INVESTIGATE THE EFFECT OF MULTIPLE DOSE BITOPERTIN ON SINGLE DOSE PHARMACOKINETICS OF MIDAZOLAM IN HEALTHY VOLUNTEERS
Status: Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 27 Oct 2017
Price : $35 *
At a glance
- Drugs Bitopertin (Primary) ; Midazolam
- Indications Obsessive-compulsive disorders; Schizophrenia
- Focus Pharmacokinetics
- Sponsors Roche
- 14 Oct 2014 Status changed from not yet recruiting to withdrawn prior to enrolment, as per ClinicalTrials.gov record.
- 27 Jan 2014 Planned End Date changed from 1 Feb 2014 to 1 Mar 2014 as per ClinicalTrials.gov record.
- 27 Jan 2014 Planned initiation date changed from 1 Jan 2014 to 1 Feb 2014 as per ClinicalTrials.gov record.